Patents by Inventor Mohammad Azhar

Mohammad Azhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260193700
    Abstract: The invention describes a kit for detection of a target polynucleotide using a CRISPR effector system that comprises CAS9 from Francisella novicida, a synthetic sgRNA and a detection scheme based on binding and subsequent enzymatic cleavage of the target polynucleotide. The invention also describes a method for detection of a target polynucleotide using the kit. The kit can be applied to both pathogenic and non-pathogenic polynucleotides and can be used to distinguish polynucleotides different by a single mismatch without the need for sequencing. The kit can also be used for detection of COVID-19. The kit is economical, easy to assemble and provides a robust and rapid readout that can be appropriately adapted for point of care applications.
    Type: Application
    Filed: March 5, 2026
    Publication date: July 9, 2026
    Inventors: Debojyoti Chakraborty, Souvik Maiti, Mohammad Azhar, Rhythm Phutela, Namrata Sharma, Dipanjali Sinha, Saumya Sharma, Arpit Mishra, Asgar Hussain Ansari
  • Patent number: 12674198
    Abstract: The invention describes a kit for detection of a target polynucleotide using a CRISPR effector system that comprises CAS9 from Francisella novicida, a synthetic sgRNA and a detection scheme based on binding and subsequent enzymatic cleavage of the target polynucleotide. The invention also describes a method for detection of a target polynucleotide using the kit. The kit can be applied to both pathogenic and non-pathogenic polynucleotides and can be used to distinguish polynucleotides different by a single mismatch without the need for sequencing. The kit can also be used for detection of COVID-19. The kit is economical, easy to assemble and provides a robust and rapid readout that can be appropriately adapted for point of care applications.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: July 7, 2026
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Debojyoti Chakraborty, Souvik Maiti, Mohammad Azhar, Rhythm Phutela, Namrata Sharma, Dipanjali Sinha, Saumya Sharma, Arpit Mishra, Asgar Hussain Ansari
  • Publication number: 20230031670
    Abstract: The invention describes a kit for detection of a target polynucleotide using a CRISPR effector system that comprises CAS9 from Francisella novicida, a synthetic sgRNA and a detection scheme based on binding and subsequent enzymatic cleavage of the target polynucleotide. The invention also describes a method for detection of a target polynucleotide using the kit. The kit can be el applied to both pathogenic and non-pathogenic polynucleotides and can be used to distinguish polynucleotides different by a single mismatch without the need for sequencing. The kit can also be used for detection of COVID-19. The kit is economical, easy to assemble and provides a robust and rapid readout that can be appropriately adapted for point of care applications.
    Type: Application
    Filed: December 1, 2020
    Publication date: February 2, 2023
    Inventors: Debojyoti Chakraborty, Souvk Maiti, Mohammad Azhar, Rhythm Phutela, Namrata Sharma, Dipanjali Sinha, Saumya Sharma, Arpit Mishra, Asgar Hussain Ansari